Market cap
₹52 Cr
Revenue (TTM)
₹21 Cr
P/E Ratio
16.1
P/B Ratio
2.8
Div. Yield
0 %
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
52 | 47,610 | 8,122 | 1,100 | 34 |
Revenue (₹ Cr) |
21 | 6,725 | 7,229 | 287 | 56 |
Net Profit (₹ Cr) |
3.24 | 1,128.79 | 210.43 | 28.67 | -1.45 |
Net Margin (%) |
15.18 | 16.02 | 2.88 | 9.68 | -2.56 |
RoE (%) |
19.12 | 11.51 | 11.02 | 9.14 | -4.88 |
Price to Earnings |
16.11 | 42.18 | 38.59 | 35.61 | -- |
Price-To-Book |
2.81 | 4.48 | 4.06 | 4.35 | 1.25 |
Income Statement (₹ Cr)
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Operating Revenue
|
16.80 | 5,616.50 | 6,136.05 | 239.11 | 53.52 |
|
Total Income
|
16.93 | 5,830.11 | 6,184.67 | 242.45 | 53.64 |
|
Total Expenditure
|
14.47 | 4,347.58 | 5,632.59 | 196.46 | 47.10 |
|
EBITDA
|
2.34 | 1,268.92 | 503.47 | 42.65 | 6.42 |
|
Depreciation
|
0.81 | 377.87 | 249.84 | 15.02 | 4.25 |
|
EBIT
|
1.53 | 891.05 | 253.62 | 27.63 | 2.16 |
|
Interest
|
0.61 | 42.00 | 118.95 | 6.17 | 3.90 |
|
Other Income
|
0.12 | 213.61 | 48.62 | 3.34 | 0.12 |
|
Exceptional Items
|
-- | -- | -- | 7.03 | -- |
|
Profit before Tax
|
1.04 | 1,062.66 | 183.29 | 31.83 | -1.62 |
|
Provision for Tax
|
0.29 | 364.13 | 33.06 | 6.45 | -0.15 |
|
Profit after Tax
|
0.75 | 698.53 | 150.23 | 25.38 | -1.46 |
Liabilities (₹ Cr)
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
13.78 | 9,150.74 | 1,740.56 | 208.54 | 30.75 |
|
Minority Interest
|
0.00 | -- | -0.66 | 0.16 | -- |
|
Non-Current Liabilities
|
-0.07 | 457.27 | 991.72 | 12.82 | 21.97 |
|
Current Liabilities
|
8.87 | 1,564.85 | 624.57 | 56.70 | 31.83 |
|
Total Liabilities
|
23.05 | 11,172.85 | 3,456.02 | 284.67 | 84.58 |
Assets (₹ Cr)
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
5.39 | 4,389.91 | 1,464.69 | 91.16 | 21.59 |
|
Current Assets
|
17.19 | 6,782.94 | 1,891.49 | 187.06 | 62.96 |
|
Total Assets
|
23.05 | 11,172.85 | 3,456.02 | 284.67 | 84.58 |
|
Total Debt*
|
5.07 | 269.21 | 0.00 | 11.37 | 12.26 |
|
Net Current Assets
|
8.32 | 5,218.09 | 1,266.92 | 130.35 | 31.13 |
|
Contingent Liabilities
|
0.42 | 21.38 | 13.78 | 0.60 | 0.10 |
Cashflow (₹ Cr)
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.01 | 914.73 | 540.43 | 43.83 | 17.07 |
|
Cash Flow from Investing Activities
|
-0.04 | 1,704.74 | -317.61 | -29.24 | -11.61 |
|
Cash from Financing Activities
|
0.19 | -433.48 | -227.98 | 110.64 | -5.93 |
|
Net Cash Inflow / Outflow
|
0.14 | 2,185.99 | -5.16 | 125.23 | -0.47 |
Ratios
Profitability Ratios
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
ROCE (%)
|
9.13 | 11.97 | 18.22 | 24.97 | 5.09 |
|
ROE (%)
|
5.59 | 7.82 | 9.21 | 21.40 | -4.93 |
|
ROA (%)
|
3.42 | 6.41 | 4.73 | 12.64 | -1.79 |
|
EBIT Margin (%)
|
14.64 | 26.40 | 9.00 | 19.23 | 12.22 |
|
Net Margin (%)
|
4.43 | 11.98 | 2.43 | 10.47 | -2.73 |
|
Cash Profit Margin (%)
|
9.27 | 19.16 | 6.43 | 16.89 | 5.22 |
Growth Ratios
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-23.76 | -0.85 | 9.09 | 23.53 | 4.55 |
|
EBIT Growth (%)
|
-59.17 | -1.38 | 34.23 | 76.27 | 23.91 |
|
Net Profit Growth (%)
|
-77.67 | -9.57 | 129.09 | 41.44 | -229.03 |
|
EPS Growth (%)
|
-77.67 | -9.60 | 129.29 | -35.33 | -229.03 |
|
Book Value Growth (%)
|
5.75 | 4.91 | 10.77 | 569.07 | -4.81 |
Valuation Ratios
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Price / Earnings
|
29.91 | 37.55 | 60.48 | 76.82 | 0.00 |
|
Price / Book Value
|
1.63 | 2.87 | 5.30 | 11.83 | 1.38 |
|
Dividend Yield (%)
|
0.00 | 1.13 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
10.73 | 16.15 | 15.80 | 50.94 | 7.98 |
|
Market Cap (₹ Cr)
|
22.43 | 26,233.01 | 9,091.18 | 2,440.49 | 40.13 |
Solvency Ratios
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.37 | 0.03 | 0.00 | 0.06 | 0.40 |
|
Short term debt to equity ratio
|
0.33 | -- | -- | 0.56 | 0.40 |
|
Current Ratio
|
1.94 | 4.33 | 3.03 | 3.30 | 1.98 |
|
Quick Ratio
|
1.15 | 3.26 | 0.87 | 2.97 | 0.61 |
|
Interest Coverage
|
2.71 | 26.30 | 2.54 | 6.16 | 0.59 |
Operating Efficiency Ratios
| Shree Pacetronix | Gland Pharma | Medplus Health | Laxmi Dental | Centenial Surgical | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
39.46 | 27.00 | 0.22 | 15.34 | 34.38 |
|
Asset Turnover
|
0.77 | 0.52 | 1.96 | 1.19 | 0.65 |
|
Receivable days
|
122.59 | 99.92 | 0.90 | 47.00 | 126.86 |
|
Inventory Days
|
138.71 | 108.54 | 78.76 | 33.10 | 293.26 |
|
Payable days
|
36.89 | 138.65 | 21.71 | 152.61 | 178.88 |
|
Cash Conversion Cycle
|
224.42 | 69.81 | 57.95 | -72.51 | 241.25 |